# ATN International, Inc.: financial statements, quarterly

ATNI · Nasdaq · CIK 879585 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/atni.md) · [Financials](/companies/atni/financials.md) · [Filings](/companies/atni/filings.md) · [Insiders](/companies/atni/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/atni/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [178](/filings/0001558370-24-015284.md) | [186 d](/filings/0001104659-26-028515.md) | [173](/filings/0001558370-25-007345.md) | [169](/filings/0001558370-25-011033.md) | [165](/filings/0001104659-25-109113.md) | [167 d](/filings/0001104659-26-028515.md) | [165](/filings/0001104659-26-058667.md) | [166](/filings/0001104659-26-093257.md) | [167](/filings/0001104659-25-109113.md) | [169 d](/filings/0001104659-26-028515.md) | [168](/filings/0001104659-26-058667.md) | [171](/filings/0001104659-26-093257.md) |
| Selling, general and administrative | $m | [60.8](/filings/0001558370-24-015284.md) | [58.6 d](/filings/0001104659-26-028515.md) | [61.3](/filings/0001558370-25-007345.md) | [57.7](/filings/0001558370-25-011033.md) | [53.6](/filings/0001104659-25-109113.md) | [56.3 d](/filings/0001104659-26-028515.md) | [55.2](/filings/0001104659-26-058667.md) | [56.2](/filings/0001104659-26-093257.md) | [54.3](/filings/0001104659-25-109113.md) | [53.9 d](/filings/0001104659-26-028515.md) | [56.2](/filings/0001104659-26-058667.md) | [55.3](/filings/0001104659-26-093257.md) |
| Operating income | $m | [6.8](/filings/0001558370-24-015284.md) | [3.3 d](/filings/0001104659-26-028515.md) | [4.6](/filings/0001558370-25-007345.md) | [24.3](/filings/0001558370-25-011033.md) | [(38.4)](/filings/0001104659-25-109113.md) | [8.7 d](/filings/0001104659-26-028515.md) | [2.7](/filings/0001104659-26-058667.md) | [0.2](/filings/0001104659-26-093257.md) | [9.8](/filings/0001104659-25-109113.md) | [15.7 d](/filings/0001104659-26-028515.md) | [11.7](/filings/0001104659-26-058667.md) | [240](/filings/0001104659-26-093257.md) |
| Interest expense | $m | [11.4](/filings/0001558370-23-018245.md) | [12.0 d](/filings/0001558370-24-003375.md) | [11.5](/filings/0001558370-24-007776.md) | [12.3](/filings/0001558370-25-011033.md) | [12.7](/filings/0001104659-25-109113.md) | [13.0 d](/filings/0001104659-26-028515.md) | [12.0](/filings/0001104659-26-058667.md) | [12.8](/filings/0001104659-26-093257.md) | [11.6](/filings/0001104659-25-109113.md) | [11.4 d](/filings/0001104659-26-028515.md) | [10.5](/filings/0001104659-26-058667.md) | [10.9](/filings/0001104659-26-093257.md) |
| Income tax | $m | [(0.5)](/filings/0001558370-24-015284.md) | [(2.4) d](/filings/0001104659-26-028515.md) | [1.6](/filings/0001558370-25-007345.md) | [0.2](/filings/0001558370-25-011033.md) | [(12.0)](/filings/0001104659-25-109113.md) | [(8.9) d](/filings/0001104659-26-028515.md) | [(0.2)](/filings/0001104659-26-058667.md) | [(3.8)](/filings/0001104659-26-093257.md) | [(5.1)](/filings/0001104659-25-109113.md) | [4.8 d](/filings/0001104659-26-028515.md) | [1.6](/filings/0001104659-26-058667.md) | [42.1](/filings/0001104659-26-093257.md) |
| Net income | $m | [(3.7)](/filings/0001558370-24-015284.md) | [(3.1) d](/filings/0001104659-26-028515.md) | [(7.9)](/filings/0001558370-25-007345.md) | [11.3](/filings/0001558370-25-011033.md) | [(39.5)](/filings/0001104659-25-109113.md) | [9.6 d](/filings/0001104659-26-028515.md) | [(8.9)](/filings/0001104659-26-058667.md) | [(7.0)](/filings/0001104659-26-093257.md) | [3.9](/filings/0001104659-25-109113.md) | [1.8 d](/filings/0001104659-26-028515.md) | [(2.8)](/filings/0001104659-26-058667.md) | [167](/filings/0001104659-26-093257.md) |
| Diluted EPS | $ per share | [(0.31)](/filings/0001558370-24-015284.md) | not reported | [(0.50)](/filings/0001558370-25-007345.md) | [0.50](/filings/0001558370-25-011033.md) | [(2.26)](/filings/0001104659-25-109113.md) | not reported | [(0.69)](/filings/0001104659-26-058667.md) | [(0.56)](/filings/0001104659-26-093257.md) | [0.18](/filings/0001104659-25-109113.md) | not reported | [(0.29)](/filings/0001104659-26-058667.md) | [10.71](/filings/0001104659-26-093257.md) |
| Basic EPS | $ per share | [(0.31)](/filings/0001558370-24-015284.md) | not reported | [(0.50)](/filings/0001558370-25-007345.md) | [0.50](/filings/0001558370-25-011033.md) | [(2.26)](/filings/0001104659-25-109113.md) | not reported | [(0.69)](/filings/0001104659-26-058667.md) | [(0.56)](/filings/0001104659-26-093257.md) | [0.18](/filings/0001104659-25-109113.md) | not reported | [(0.29)](/filings/0001104659-26-058667.md) | [10.77](/filings/0001104659-26-093257.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [62.1](/filings/0001558370-23-018245.md) | [49.2](/filings/0001558370-25-003128.md) | [56.5](/filings/0001558370-24-007776.md) | [58.9](/filings/0001558370-24-011708.md) | [101](/filings/0001558370-24-015284.md) | [73.4](/filings/0001104659-26-028515.md) | [83.5](/filings/0001558370-25-007345.md) | [99.0](/filings/0001558370-25-011033.md) | [106](/filings/0001104659-25-109113.md) | [102](/filings/0001104659-26-093257.md) | [109](/filings/0001104659-26-058667.md) | [318](/filings/0001104659-26-093257.md) |
| Current assets | $m | [267](/filings/0001558370-23-018245.md) | [281](/filings/0001558370-25-003128.md) | [290](/filings/0001558370-24-007776.md) | [296](/filings/0001558370-24-011708.md) | [326](/filings/0001558370-24-015284.md) | [309](/filings/0001104659-26-028515.md) | [306](/filings/0001558370-25-007345.md) | [328](/filings/0001558370-25-011033.md) | [327](/filings/0001104659-25-109113.md) | [328](/filings/0001104659-26-093257.md) | [335](/filings/0001104659-26-058667.md) | [542](/filings/0001104659-26-093257.md) |
| Total assets | $m | [1,751](/filings/0001558370-23-018245.md) | [1,784](/filings/0001558370-25-003128.md) | [1,779](/filings/0001558370-24-007776.md) | [1,772](/filings/0001558370-24-011708.md) | [1,751](/filings/0001558370-24-015284.md) | [1,727](/filings/0001104659-26-028515.md) | [1,707](/filings/0001558370-25-007345.md) | [1,707](/filings/0001558370-25-011033.md) | [1,699](/filings/0001104659-25-109113.md) | [1,673](/filings/0001104659-26-093257.md) | [1,675](/filings/0001104659-26-058667.md) | [1,880](/filings/0001104659-26-093257.md) |
| Current liabilities | $m | [263](/filings/0001558370-23-018245.md) | [293](/filings/0001558370-25-003128.md) | [274](/filings/0001558370-24-007776.md) | [269](/filings/0001558370-24-011708.md) | [268](/filings/0001558370-24-015284.md) | [267](/filings/0001104659-26-028515.md) | [264](/filings/0001558370-25-007345.md) | [269](/filings/0001558370-25-011033.md) | [260](/filings/0001104659-25-109113.md) | [263](/filings/0001104659-26-093257.md) | [277](/filings/0001104659-26-058667.md) | [333](/filings/0001104659-26-093257.md) |
| Total liabilities | $m | [1,010](/filings/0001558370-23-018245.md) | [1,060](/filings/0001558370-25-003128.md) | [1,066](/filings/0001558370-24-007776.md) | [1,060](/filings/0001558370-24-011708.md) | [1,082](/filings/0001558370-24-015284.md) | [1,055](/filings/0001104659-26-028515.md) | [1,049](/filings/0001558370-25-007345.md) | [1,061](/filings/0001558370-25-011033.md) | [1,051](/filings/0001104659-25-109113.md) | [1,032](/filings/0001104659-26-093257.md) | [1,041](/filings/0001104659-26-058667.md) | [1,063](/filings/0001104659-26-093257.md) |
| Long-term debt | $m | [477](/filings/0001558370-23-018245.md) | [493](/filings/0001558370-25-003128.md) | [521](/filings/0001558370-24-007776.md) | [524](/filings/0001558370-24-011708.md) | [561](/filings/0001558370-24-015284.md) | [549](/filings/0001104659-26-028515.md) | [554](/filings/0001558370-25-007345.md) | [569](/filings/0001558370-25-011033.md) | [570](/filings/0001104659-25-109113.md) | [549](/filings/0001104659-26-093257.md) | [549](/filings/0001104659-26-058667.md) | [490](/filings/0001104659-26-093257.md) |
| Current portion of debt | $m | [21.3](/filings/0001558370-23-018245.md) | [24.3](/filings/0001558370-25-003128.md) | [20.5](/filings/0001558370-24-007776.md) | [16.6](/filings/0001558370-24-011708.md) | [7.4](/filings/0001558370-24-015284.md) | [8.2](/filings/0001104659-26-028515.md) | [8.2](/filings/0001558370-25-007345.md) | [14.9](/filings/0001558370-25-011033.md) | [9.9](/filings/0001104659-25-109113.md) | [15.8](/filings/0001104659-26-093257.md) | [21.6](/filings/0001104659-26-058667.md) | [23.7](/filings/0001104659-26-093257.md) |
| Shareholders' equity | $m | [546](/filings/0001558370-23-018245.md) | [541](/filings/0001558370-25-003128.md) | [530](/filings/0001558370-24-007776.md) | [527](/filings/0001558370-24-011708.md) | [491](/filings/0001558370-24-015284.md) | [489](/filings/0001104659-26-028515.md) | [473](/filings/0001558370-25-007345.md) | [459](/filings/0001558370-25-011033.md) | [452](/filings/0001104659-25-109113.md) | [444](/filings/0001104659-26-093257.md) | [434](/filings/0001104659-26-058667.md) | [599](/filings/0001104659-26-093257.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [29.2 d](/filings/0001558370-24-015284.md) | [22.1 d](/filings/0001104659-26-028515.md) | [23.2](/filings/0001558370-25-007345.md) | [35.2 d](/filings/0001558370-25-011033.md) | [39.0 d](/filings/0001104659-25-109113.md) | [30.5 d](/filings/0001104659-26-028515.md) | [35.9](/filings/0001104659-26-058667.md) | [23.9 d](/filings/0001104659-26-093257.md) | [37.8 d](/filings/0001104659-25-109113.md) | [36.2 d](/filings/0001104659-26-028515.md) | [29.8](/filings/0001104659-26-058667.md) | [23.8 d](/filings/0001104659-26-093257.md) |
| Capital expenditure | $m | [37.2 d](/filings/0001558370-24-015284.md) | [36.7 d](/filings/0001104659-26-028515.md) | [36.0](/filings/0001558370-25-007345.md) | [25.8 d](/filings/0001558370-25-011033.md) | [23.8 d](/filings/0001104659-25-109113.md) | [24.7 d](/filings/0001104659-26-028515.md) | [20.8](/filings/0001104659-26-058667.md) | [21.2 d](/filings/0001104659-26-093257.md) | [18.9 d](/filings/0001104659-25-109113.md) | [29.1 d](/filings/0001104659-26-028515.md) | [21.0](/filings/0001104659-26-058667.md) | [17.2 d](/filings/0001104659-26-093257.md) |
| Dividends paid | $m | [3.3 d](/filings/0001558370-24-015284.md) | [3.3 d](/filings/0001104659-26-028515.md) | [3.7](/filings/0001558370-25-007345.md) | [3.7 d](/filings/0001558370-25-011033.md) | [3.6 d](/filings/0001104659-25-109113.md) | [3.6 d](/filings/0001104659-26-028515.md) | [3.6](/filings/0001104659-26-058667.md) | [3.7 d](/filings/0001104659-26-093257.md) | [4.2 d](/filings/0001104659-25-109113.md) | [4.2 d](/filings/0001104659-26-028515.md) | [4.2](/filings/0001104659-26-058667.md) | [4.2 d](/filings/0001104659-26-093257.md) |
| Share repurchases | $m | [4.9 d](/filings/0001558370-24-015284.md) | [3.3 d](/filings/0001104659-26-028515.md) | [0.1](/filings/0001558370-25-007345.md) | [9.9 d](/filings/0001558370-25-011033.md) | [0.0 d](/filings/0001104659-25-109113.md) | [0.0 d](/filings/0001104659-26-028515.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [15.8](/filings/0001558370-23-018245.md) | [15.8](/filings/0001558370-24-007776.md) | [15.7](/filings/0001558370-24-011708.md) | [15.6](/filings/0001558370-24-015284.md) | [15.4](/filings/0001558370-25-007345.md) | [15.3](/filings/0001558370-25-011033.md) | [15.1](/filings/0001104659-25-109113.md) | [15.1](/filings/0001104659-26-058667.md) | [15.2](/filings/0001104659-26-093257.md) | [15.3](/filings/0001104659-25-109113.md) | [15.3](/filings/0001104659-26-058667.md) | [15.5](/filings/0001104659-26-093257.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 15,403,357 at 2026-08-10, from the cover of the [10-Q filed 2026-08-10](/filings/0001104659-26-093257.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. No prices; not investment advice.